Literature DB >> 28279664

Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

Matthew C Altman1, Jake Lenington2, Steve Bronson2, Andrew G Ayars3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28279664     DOI: 10.1016/j.jaip.2017.01.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  16 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

2.  Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series.

Authors:  Richard Paul Ramonell; F Eun-Hyung Lee; Colin Swenson; Merin Kuruvilla
Journal:  J Allergy Clin Immunol Pract       Date:  2019-12-04

Review 3.  Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.

Authors:  Florence Roufosse
Journal:  Front Med (Lausanne)       Date:  2018-04-06

4.  Recurrence of allergic bronchopulmonary aspergillosis after adjunctive surgery for aspergilloma: a case report with long-term follow-up.

Authors:  Kohei Horiuchi; Takanori Asakura; Naoki Hasegawa; Fumitake Saito
Journal:  BMC Pulm Med       Date:  2018-12-04       Impact factor: 3.317

5.  Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature.

Authors:  Shuko Hirota; Yoichi Kobayashi; Takashi Ishiguro; Takashi Nishida; Naho Kagiyama; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Respir Med Case Rep       Date:  2018-11-24

6.  Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection.

Authors:  Hironobu Tsubouchi; Shinpei Tsuchida; Shigehisa Yanagi; Takafumi Shigekusa; Mariko Miura; Kenjiro Sakaguchi; Nobuhiro Matsumoto; Masamitsu Nakazato
Journal:  Respir Med Case Rep       Date:  2019-06-05

Review 7.  Targeting eosinophils: severe asthma and beyond.

Authors:  Marco Caminati; Francesco Menzella; Lucia Guidolin; Gianenrico Senna
Journal:  Drugs Context       Date:  2019-07-23

8.  Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan.

Authors:  Hiroaki Matsuura; Keiichi Fujiwara; Hiroki Omori; Kiriko Onishi; Tadahiro Kuribayashi; Sho Mitsumune; Yuki Takigawa; Kenichiro Kudo; Daisuke Minami; Akiko Sato; Ken Sato; Takuo Shibayama
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

9.  A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.

Authors:  Takeshi Terashima; Taro Shinozaki; Eri Iwami; Takahiro Nakajima; Tatsu Matsuzaki
Journal:  BMC Pulm Med       Date:  2018-03-27       Impact factor: 3.317

Review 10.  Childhood allergic bronchopulmonary aspergillosis.

Authors:  Kana Ram Jat; Pankaj C Vaidya; Joseph L Mathew; Sunil Jondhale; Meenu Singh
Journal:  Lung India       Date:  2018 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.